Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Treatment of upper GI tumours in the time of precision oncology

Biomarker of gastroesophageal cancer: What’s standard of care and what’s on the horizon?

Date

18 Oct 2020

Session

Treatment of upper GI tumours in the time of precision oncology

Topics

Tumour Site

Gastrointestinal Cancers

Presenters

Kei Muro

Authors

K. Muro

Author affiliations

Department Of Clinical Oncology, Aichi Cancer Center Hospital, 464-8681 - Nagoya/JP

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

18 Oct 2020

Update on predictive and prognostic roles of circulating tumor DNA

Presenter: Nicole van Grieken

Session: Treatment of upper GI tumours in the time of precision oncology

Resources:

Slides

Webcast

18 Oct 2020

Immune checkpoint inhibitors: Clinical use and response prediction

Presenter: Yelena Janjigian

Session: Treatment of upper GI tumours in the time of precision oncology

Resources:

Slides

Webcast

18 Oct 2020

Biomarker of hepatobiliary and pancreatic cancer: Is there a standard of care and what’s on the horizon?

Presenter: Arndt Vogel

Session: Treatment of upper GI tumours in the time of precision oncology

Resources:

Slides

Webcast

18 Oct 2020

Q&A and live discussion

Presenter: Silvia Giordano

Session: Treatment of upper GI tumours in the time of precision oncology

Resources:

Webcast